"/> Novus Biologicals™ Peptide bloquant d’anticorps UB… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps UBQLN4/CIP75

Réf. : BL-RE-050995Réf. fabricant : 18264407
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
56893
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77054. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 18 amino acids near the amino terminus of human CIP75.

Points forts

Source

Synthetic

(Accession #: Q9NRR5) The UBQLN4/CIP75 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-050995
Réf. fabricant18264407
Gene ID (Entrez)56893
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77054. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneA1Uataxin-1 ubiquitin-like interacting protein, Ataxin-1 ubiquitin-like-interacting protein A1U, C1orf6ubiquilin-4, chromosome 1 open reading frame 6, UBINCIP75, ubiquilin 4
Symbole de gène(s)UBQLN4
Type de produitUBQLN4/CIP75
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne18 amino acids near the amino terminus of human CIP75
Une question, une configuration particulière ?
Contactez-nous pour un devis.